Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation

OBJECTIVE: To determine the effectiveness of erenumab in treating headaches in idiopathic intracranial hypertension (IIH) in whom papilledema had resolved. BACKGROUND: Disability in IIH is predominantly driven by debilitating headaches with no evidence for the use of preventative therapies. Headache...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Headache
Auteurs principaux: Yiangou, Andreas, Mitchell, James L., Fisher, Claire, Edwards, Julie, Vijay, Vivek, Alimajstorovic, Zerin, Grech, Olivia, Lavery, Gareth G., Mollan, Susan P., Sinclair, Alexandra J.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Research Submissions
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7898289/
https://ncbi.nlm.nih.gov/pubmed/33316102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.14026
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires